Skip to main content

Los Angeles Capital Management Llc

Source: SEC Form 13F · as of Mar 2026

Los Angeles Capital Management Llc holds 104 biotech & pharma companies tracked by BioSniper, totaling $515.6M in value as of Mar 2026 (SEC Form 13F).

Companies held

104

Total value held

$515.6M

BioSniper AIPage context preserved

Prepared research question

What matters most for Incyte Corp. (INCY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
INCYIncyte Corp.2,144,847$201.9M
EXELEXELIXIS, INC.3,102,634$133.1M
REGNREGENERON PHARMACEUTICALS, INC.78,880$60.9M
ALNYALNYLAM PHARMACEUTICALS, INC.88,278$29.2M
BMRNBIOMARIN PHARMACEUTICAL INC407,379$23.0M
GILDGILEAD SCIENCES, INC.73,460$10.2M
JAZZJazz Pharmaceuticals plc29,818$5.6M
PTCTPTC THERAPEUTICS, INC.71,660$4.9M
HRMYHarmony Biosciences Holdings, Inc.166,198$4.7M
ARQTArcutis Biotherapeutics, Inc.154,422$3.6M
APLSApellis Pharmaceuticals, Inc.85,913$3.5M
ADMAADMA BIOLOGICS, INC.272,776$2.5M
KROSKeros Therapeutics, Inc.172,196$1.9M
ANIPANI PHARMACEUTICALS INC21,817$1.7M
OGNOrganon & Co.246,852$1.5M
TNGXTango Therapeutics, Inc.63,220$1.3M
ARWRARROWHEAD PHARMACEUTICALS, INC.20,970$1.3M
INVAInnoviva, Inc.53,533$1.2M
ORGOOrganogenesis Holdings Inc.491,841$1.2M
COGTCogent Biosciences, Inc.29,086$1.1M
SLNOSOLENO THERAPEUTICS INC33,372$1.1M
ACADACADIA PHARMACEUTICALS INC49,934$1.1M
RXRXRECURSION PHARMACEUTICALS, INC.335,624$1.0M
LGNDLigand Pharmaceuticals Incorporated5,150$1.0M
NUVLNuvalent, Inc.9,939$1.0M
ZYMEZymeworks Inc.39,750$995K
STOKStoke Therapeutics, Inc.30,479$992K
ANABANAPTYSBIO, INC15,664$869K
TGTXTG THERAPEUTICS, INC.24,371$810K
RYTMRHYTHM PHARMACEUTICALS, INC.9,219$802K
LQDALiquidia Corp21,031$794K
KNSAKiniksa Pharmaceuticals International, plc16,229$781K
TVTXTravere Therapeutics, Inc.25,218$749K
IOVAIOVANCE BIOTHERAPEUTICS, INC.179,159$629K
BIOABioAge Labs, Inc.33,899$593K
ORICOric Pharmaceuticals, Inc.43,137$547K
AXSMAxsome Therapeutics, Inc.3,178$537K
BBIOBridgeBio Pharma, Inc.7,142$530K
PTGXProtagonist Therapeutics, Inc4,727$498K
TERNTerns Pharmaceuticals, Inc.7,994$421K
SIGASIGA TECHNOLOGIES INC69,082$370K
ANNXAnnexon, Inc.62,073$344K
LENZLENZ Therapeutics, Inc.33,071$303K
SYRESpyre Therapeutics, Inc.5,858$295K
MAZEMaze Therapeutics, Inc.9,420$281K
NGNENeurogene Inc.13,793$278K
SLDBSolid Biosciences Inc.37,420$269K
FDMT4D Molecular Therapeutics, Inc.27,589$257K
IRONDisc Medicine, Inc.3,952$253K
PRTAPROTHENA CORP PUBLIC LTD CO24,419$237K
VCELVericel Corp7,188$231K
SANASana Biotechnology, Inc.74,827$216K
HRTXHERON THERAPEUTICS, INC. /DE/243,003$194K
SRRKScholar Rock Holding Corp3,697$182K
SIONSionna Therapeutics, Inc.4,116$165K
INSMINSMED Inc936$153K
ABEOABEONA THERAPEUTICS INC.33,561$150K
ARVNARVINAS, INC.13,125$139K
RGNXREGENXBIO Inc.13,959$117K
FATEFATE THERAPEUTICS INC95,185$114K
PCVXVaxcyte, Inc.1,590$92K
MRNAModerna, Inc.1,664$85K
LRMRLarimar Therapeutics, Inc.18,022$81K
CYTKCYTOKINETICS INC1,131$75K
RVMDREVOLUTION MEDICINES, INC.747$73K
IONSIONIS PHARMACEUTICALS INC700$53K
IMVTImmunovant, Inc.2,017$50K
DNTHDianthus Therapeutics, Inc. /DE/465$39K
ORKAOruka Therapeutics, Inc.719$35K
AGIOAGIOS PHARMACEUTICALS, INC.950$32K
RLAYRelay Therapeutics, Inc.2,989$30K
IBRXImmunityBio, Inc.3,292$25K
FOLDAMICUS THERAPEUTICS, INC.1,252$18K
DNLIDenali Therapeutics Inc.927$18K
VKTXViking Therapeutics, Inc.461$15K
KALVKalVista Pharmaceuticals, Inc.732$15K
SUPNSUPERNUS PHARMACEUTICALS, INC.275$14K
DFTXDefinium Therapeutics Inc.618$12K
APGEApogee Therapeutics, Inc.136$11K
BEAMBeam Therapeutics Inc.449$11K
OLMAOlema Pharmaceuticals, Inc.654$10K
SMMTSummit Therapeutics Inc.514$10K
NUVBNuvation Bio Inc.2,157$9K
VRDNViridian Therapeutics, Inc.\DE473$9K
NKTRNEKTAR THERAPEUTICS127$9K
CAPRCAPRICOR THERAPEUTICS, INC.278$8K
CLDXCelldex Therapeutics, Inc.262$8K
NTLAIntellia Therapeutics, Inc.617$8K
RCUSArcus Biosciences, Inc.347$7K
KODKodiak Sciences Inc.182$7K
KURAKura Oncology, Inc.823$7K
ADPTAdaptive Biotechnologies Corp474$7K
NRIXNurix Therapeutics, Inc.394$6K
HROWHARROW, INC.170$6K
XOMAXOMA Royalty Corporation190$6K
ARDXARDELYX, INC.927$6K
XERSXeris Biopharma Holdings, Inc.791$5K
CGEMCullinan Therapeutics, Inc.306$4K
OCULOCULAR THERAPEUTIX, INC426$4K
BHVNBiohaven Ltd.379$3K
FLGTFulgent Genetics Inc.178$3K
AVXLANAVEX LIFE SCIENCES CORP.627$2K
SPRYARS Pharmaceuticals, Inc.147$1K
TNXPTonix Pharmaceuticals Holding Corp.76$1K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.